vs

Side-by-side financial comparison of Clorox (CLX) and Qorvo, Inc. (QRVO). Click either name above to swap in a different company.

Clorox is the larger business by last-quarter revenue ($1.7B vs $993.0M, roughly 1.7× Qorvo, Inc.). Qorvo, Inc. runs the higher net margin — 16.5% vs 9.4%, a 7.1% gap on every dollar of revenue. On growth, Qorvo, Inc. posted the faster year-over-year revenue change (8.4% vs 0.3%). Over the past eight quarters, Qorvo, Inc.'s revenue compounded faster (2.7% CAGR vs -8.3%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

Qorvo, Inc. is an American multinational company specializing in products for wireless, wired, and power markets. The company was created by the merger of TriQuint Semiconductor and RF Micro Devices, which was announced in 2014 and completed on January 1, 2015. It trades on Nasdaq under the ticker symbol QRVO. The headquarters for the company originally were in both Hillsboro, Oregon, and Greensboro, North Carolina, but in mid-2016 the company began referring to its North Carolina site as its...

CLX vs QRVO — Head-to-Head

Bigger by revenue
CLX
CLX
1.7× larger
CLX
$1.7B
$993.0M
QRVO
Growing faster (revenue YoY)
QRVO
QRVO
+8.1% gap
QRVO
8.4%
0.3%
CLX
Higher net margin
QRVO
QRVO
7.1% more per $
QRVO
16.5%
9.4%
CLX
Faster 2-yr revenue CAGR
QRVO
QRVO
Annualised
QRVO
2.7%
-8.3%
CLX

Income Statement — Q2 FY2026 vs Q3 FY2026

Metric
CLX
CLX
QRVO
QRVO
Revenue
$1.7B
$993.0M
Net Profit
$157.0M
$164.1M
Gross Margin
43.2%
46.7%
Operating Margin
19.4%
Net Margin
9.4%
16.5%
Revenue YoY
0.3%
8.4%
Net Profit YoY
-15.6%
297.5%
EPS (diluted)
$1.29
$1.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
QRVO
QRVO
Q4 25
$1.7B
$993.0M
Q3 25
$1.1B
Q2 25
$2.0B
$818.8M
Q1 25
$1.7B
$869.5M
Q4 24
$1.7B
$916.3M
Q3 24
$1.8B
$1.0B
Q2 24
$1.9B
$886.7M
Q1 24
$1.8B
$941.0M
Net Profit
CLX
CLX
QRVO
QRVO
Q4 25
$157.0M
$164.1M
Q3 25
$119.6M
Q2 25
$332.0M
$25.6M
Q1 25
$186.0M
$31.4M
Q4 24
$193.0M
$41.3M
Q3 24
$99.0M
$-17.4M
Q2 24
$216.0M
$414.0K
Q1 24
$-51.0M
$2.7M
Gross Margin
CLX
CLX
QRVO
QRVO
Q4 25
43.2%
46.7%
Q3 25
47.0%
Q2 25
46.5%
40.5%
Q1 25
44.6%
42.2%
Q4 24
43.8%
42.7%
Q3 24
45.8%
42.6%
Q2 24
46.5%
37.5%
Q1 24
42.2%
40.6%
Operating Margin
CLX
CLX
QRVO
QRVO
Q4 25
19.4%
Q3 25
14.9%
Q2 25
20.6%
3.7%
Q1 25
15.2%
3.2%
Q4 24
14.1%
5.8%
Q3 24
10.0%
0.9%
Q2 24
14.5%
0.5%
Q1 24
-2.3%
3.2%
Net Margin
CLX
CLX
QRVO
QRVO
Q4 25
9.4%
16.5%
Q3 25
11.3%
Q2 25
16.7%
3.1%
Q1 25
11.2%
3.6%
Q4 24
11.4%
4.5%
Q3 24
5.6%
-1.7%
Q2 24
11.4%
0.0%
Q1 24
-2.8%
0.3%
EPS (diluted)
CLX
CLX
QRVO
QRVO
Q4 25
$1.29
$1.75
Q3 25
$1.28
Q2 25
$2.68
$0.27
Q1 25
$1.50
$0.33
Q4 24
$1.54
$0.43
Q3 24
$0.80
$-0.18
Q2 24
$1.74
$0.00
Q1 24
$-0.41
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
QRVO
QRVO
Cash + ST InvestmentsLiquidity on hand
$227.0M
$1.3B
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$-125.0M
$3.7B
Total Assets
$5.6B
$6.2B
Debt / EquityLower = less leverage
0.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
QRVO
QRVO
Q4 25
$227.0M
$1.3B
Q3 25
$1.1B
Q2 25
$167.0M
$1.2B
Q1 25
$226.0M
$1.0B
Q4 24
$290.0M
$769.4M
Q3 24
$278.0M
$1.1B
Q2 24
$202.0M
$1.1B
Q1 24
$219.0M
$1.0B
Total Debt
CLX
CLX
QRVO
QRVO
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$2.5B
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$2.5B
$1.5B
Q1 24
$1.5B
Stockholders' Equity
CLX
CLX
QRVO
QRVO
Q4 25
$-125.0M
$3.7B
Q3 25
$3.5B
Q2 25
$321.0M
$3.4B
Q1 25
$27.0M
$3.4B
Q4 24
$-41.0M
$3.4B
Q3 24
$60.0M
$3.4B
Q2 24
$328.0M
$3.5B
Q1 24
$91.0M
$3.6B
Total Assets
CLX
CLX
QRVO
QRVO
Q4 25
$5.6B
$6.2B
Q3 25
$6.1B
Q2 25
$5.6B
$6.0B
Q1 25
$5.5B
$5.9B
Q4 24
$5.6B
$6.0B
Q3 24
$5.5B
$6.5B
Q2 24
$5.8B
$6.4B
Q1 24
$5.8B
$6.6B
Debt / Equity
CLX
CLX
QRVO
QRVO
Q4 25
0.42×
Q3 25
0.44×
Q2 25
7.74×
0.45×
Q1 25
0.46×
Q4 24
0.46×
Q3 24
0.45×
Q2 24
7.56×
0.44×
Q1 24
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLX
CLX
QRVO
QRVO
Operating Cash FlowLast quarter
$265.4M
Free Cash FlowOCF − Capex
$236.9M
FCF MarginFCF / Revenue
23.9%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
1.62×
TTM Free Cash FlowTrailing 4 quarters
$595.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLX
CLX
QRVO
QRVO
Q4 25
$265.4M
Q3 25
$84.0M
Q2 25
$294.0M
$182.9M
Q1 25
$286.0M
$199.2M
Q4 24
$180.0M
$214.1M
Q3 24
$221.0M
$127.8M
Q2 24
$340.0M
$81.1M
Q1 24
$182.0M
Free Cash Flow
CLX
CLX
QRVO
QRVO
Q4 25
$236.9M
Q3 25
$42.2M
Q2 25
$219.0M
$145.4M
Q1 25
$233.0M
$170.7M
Q4 24
$127.0M
$176.2M
Q3 24
$182.0M
$94.8M
Q2 24
$259.0M
$42.9M
Q1 24
$127.0M
FCF Margin
CLX
CLX
QRVO
QRVO
Q4 25
23.9%
Q3 25
4.0%
Q2 25
11.0%
17.8%
Q1 25
14.0%
19.6%
Q4 24
7.5%
19.2%
Q3 24
10.3%
9.1%
Q2 24
13.6%
4.8%
Q1 24
7.0%
Capex Intensity
CLX
CLX
QRVO
QRVO
Q4 25
2.9%
Q3 25
3.9%
Q2 25
3.8%
4.6%
Q1 25
3.2%
3.3%
Q4 24
3.1%
4.1%
Q3 24
2.2%
3.2%
Q2 24
4.3%
4.3%
Q1 24
3.0%
Cash Conversion
CLX
CLX
QRVO
QRVO
Q4 25
1.62×
Q3 25
0.70×
Q2 25
0.89×
7.15×
Q1 25
1.54×
6.35×
Q4 24
0.93×
5.19×
Q3 24
2.23×
Q2 24
1.57×
195.86×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLX
CLX

Health And Wellness$643.0M38%
Household$419.0M25%
Lifestyle$321.0M19%
Other$290.0M17%

QRVO
QRVO

ACG$690.8M70%
HPA$190.9M19%
CSG$111.3M11%

Related Comparisons